OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 75 citing articles:

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
Feng‐Jiao Li, Hui‐Zhi Long, Ziwei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 192

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 158

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
Guang Lei, Li Zhuang, Boyi Gan
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 513-534
Open Access | Times Cited: 106

Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
Amir Ajoolabady, Daolin Tang, Guido Kroemer, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 2, pp. 190-205
Open Access | Times Cited: 73

Ferroptosis: a double-edged sword mediating immune tolerance of cancer
Qin Dang, Ziqi Sun, Yang Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 72

Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma
Zhengcong Cao, Xiao Liu, Wangqian Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23746-23760
Open Access | Times Cited: 65

The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 59

Ferroptotic therapy in cancer: benefits, side effects, and risks
Jiandong Diao, Yuanyuan Jia, Enyong Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 23

S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism
Min Yang, Weiwei Cui, Xiaoting Lv, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54

A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption
Yidan Lai, Nong Lu, Shuangling Luo, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13041-13051
Closed Access | Times Cited: 50

Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Xuan Liu, Yiqian Zhang, Xuyi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 43

JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis
Shan Lei, Wenpeng Cao, Zhirui Zeng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 39

Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
Qiaolin Liu, Yuliang Zhao, Huige Zhou, et al.
Regenerative Biomaterials (2023) Vol. 10
Open Access | Times Cited: 37

Metabolomics in drug research and development: The recent advances in technologies and applications
Huanhuan Pang, Zeping Hu
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3238-3251
Open Access | Times Cited: 31

Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy
Qiuhong Li, Kexin Chen, Tianyi Zhang, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175913-175913
Closed Access | Times Cited: 31

Ferroptosis in hepatocellular carcinoma: from bench to bedside
Daolin Tang, Guido Kroemer, Rui Kang
Hepatology (2023) Vol. 80, Iss. 3, pp. 721-739
Closed Access | Times Cited: 27

Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma
Yujia Li, Mei Guo, Yangling Qiu, et al.
Redox Biology (2023) Vol. 69, pp. 102971-102971
Open Access | Times Cited: 27

Ferroptosis in gastrointestinal cancer: from mechanisms to implications
Ruoxi Zhang, Rui Kang, Daolin Tang
Cancer Letters (2023) Vol. 561, pp. 216147-216147
Open Access | Times Cited: 24

From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma
Zijian Wang, Chunyang Zhou, Yiming Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116074-116074
Open Access | Times Cited: 22

Amorphous metal–organic frameworks: Pioneering frontiers in cancer diagnostics and therapeutics
Jingqi Zhao, Yaowen Zhang, Yankun Luo, et al.
Chemical Engineering Journal (2024) Vol. 492, pp. 152295-152295
Open Access | Times Cited: 11

Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy
Debiao Xiang, Lili Zhou, Ruizhen Yang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2091-2112
Open Access | Times Cited: 9

The protective role of baicalin regulation of autophagy in cancers
Qí Zhāng, Shiyun Guo, Han Ge, et al.
Cytotechnology (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 1

Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters
Min Gao, Kexin Fan, Yuhan Chen, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2022) Vol. 49, Iss. 10, pp. 913-926
Closed Access | Times Cited: 36

Page 1 - Next Page

Scroll to top